A Revised Estimate of the Burden of Illness of Gout()

por Wertheimer, Albert, Morlock, Robert, Becker, Michael A.
Publicado 2013

Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics

por Terkeltaub, Robert, Bushinsky, David A, Becker, Michael A
Publicado 2006

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study

por Gunawardhana, Lhanoo, Becker, Michael A., Whelton, Andrew, Hunt, Barbara, Castillo, Majin, Saag, Kenneth
Publicado 2018

Infusion-Related Reactions With Pegloticase, a Recombinant Uricase for the Treatment of Chronic Gout Refractory to Conventional Therapy

por Baraf, Herbert S. B., Yood, Robert A., Ottery, Faith D., Sundy, John S., Becker, Michael A.
Publicado 2014

Robust Tipless Positioning Device for Near-Field Investigations: Press and Roll Scan (PROscan)

por Liu, Hsuan-Wei, Becker, Michael A., Matsuzaki, Korenobu, Kumar, Randhir, Götzinger, Stephan, Sandoghdar, Vahid
Publicado 2022

Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo‐Controlled Study

por Saag, Kenneth G., Becker, Michael A., Whelton, Andrew, Hunt, Barbara, Castillo, Majin, Kisfalvi, Krisztina, Gunawardhana, Lhanoo
Publicado 2018

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

por Lipsky, Peter E, Calabrese, Leonard H, Kavanaugh, Arthur, Sundy, John S, Wright, David, Wolfson, Marsha, Becker, Michael A
Publicado 2014

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

por Becker, Michael A, Schumacher, H Ralph, Espinoza, Luis R, Wells, Alvin F, MacDonald, Patricia, Lloyd, Eric, Lademacher, Christopher
Publicado 2010

Long-term safety of pegloticase in chronic gout refractory to conventional treatment

por Becker, Michael A, Baraf, Herbert S B, Yood, Robert A, Dillon, Aileen, Vázquez-Mellado, Janitzia, Ottery, Faith D, Khanna, Dinesh, Sundy, John S
Publicado 2013

Unraveling the Origin of the Long Fluorescence Decay Component of Cesium Lead Halide Perovskite Nanocrystals

por Becker, Michael A., Bernasconi, Caterina, Bodnarchuk, Maryna I., Rainò, Gabriele, Kovalenko, Maksym V., Norris, David J., Mahrt, Rainer F., Stöferle, Thilo
Publicado 2020

Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in...

por Saag, Kenneth G., Becker, Michael A., White, William B., Whelton, Andrew, Borer, Jeffrey S., Gorelick, Philip B., Hunt, Barbara, Castillo, Majin, Gunawardhana, Lhanoo
Publicado 2022

Tophus burden reduction with pegloticase: results from phase 3 randomized trials and open-label extension in patients with chronic gout refractory to conventional therapy

por Baraf, Herbert SB, Becker, Michael A, Gutierrez-Urena, Sergio R, Treadwell, Edward L, Vazquez-Mellado, Janitzia, Rehrig, Claudia D, Ottery, Faith D, Sundy, John S, Yood, Robert A
Publicado 2013